2013 R&D 100 Winner
Abbott's Absorb Bioresorbable Vascular ScaffoldCoronary artery disease (CAD) is a condition in which the arteries that supply blood to the heart become narrowed or blocked by a buildup of plaque. Over time, plaque hardens and narrows the coronary arteries, limiting the flow of oxygen-rich blood to the heart muscle, which could cause angina or a heart attack.

Abbott’s Absorb Bioresorbable Vascular Scaffold is the first drug-eluting, fully bioresorbable vascular scaffold technology to reach the market. The scaffold is delivered via a minimally invasive, catheter-based procedure involving a small incision in the groin or wrist to access the clogged artery. The scaffold is made of polylactide, a naturally dissolvable material that is commonly used in medical implants such as dissolving sutures. Similar to a drug-eluting metallic stent, Absorb works by opening a clogged vessel and restoring blood flow to the heart. Unlike metallic stents, Absorb’s unique structure and material enables it to dissolve into the blood vessel, leaving behind a treated vessel that may resume more natural function and movement because it is free of a permanent metallic implant.

Bioresorbable arterial scaffold


Development Team

The Absorb Bioresorbable Vascular Scaffold Development Team from Abbott
John Capek, Principal Developer
Richard Rapoza